Company profile
Kneevoice, Inc.
Kneevoice, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on February 6, 2026 and the most recent on February 6, 2026 (Kneevoice Cartilage Evaluation System (750-3600-001)). Its most common review panel is Cardiovascular (1 device).
1AI devices
2026First decision
2026Latest decision
1Specialties
Timeline
- Kneevoice Cartilage Evaluation System (750-3600-001) · Cardiovascular · DQD